SCHEMBL3138363

SCHEMBL3138363

COc1ccc(CN2CCC(n3c(C)nc4cc(OC(=O)O)ccc43)CC2)cc1OC1CCCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
SSTR5 P35346 1/20 0.46
PKM P14618 2/20 0.46
MAPK1 P28482 2/20 0.45
GLA P06280 1/20 0.45
UBE2N P61088 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
HSD17B10 Q99714 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
POLB P06746 1/20 0.41
PDE4B Q07343 2/20 0.41
LMNA P02545 2/20 0.41
PDE4A P27815 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
USP2 O75604 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3132253 0.91 SSTR5 (0.44) ALDH1A1SSTR5PKMMAPK1GLA
SCHEMBL3094321 0.89 L3MBTL1 (0.57) ALDH1A1SSTR5PKMMAPK1GLA
SCHEMBL3138202 0.89 ALDH1A1 (0.48) ALDH1A1PKMMAPK1GLAUBE2N
SCHEMBL3130955 0.87 SSTR5 (0.47) ALDH1A1SSTR5PKMMAPK1GLA
SCHEMBL3130713 0.87 ALDH1A1 (0.48) ALDH1A1SSTR5PKMMAPK1GLA
SCHEMBL3132297 0.85 MAPK1 (0.51) ALDH1A1SSTR5MAPK1UBE2NNPSR1
SCHEMBL3134424 0.83 OPRM1 (0.53) SMN1; SMN2
SCHEMBL3138408 0.81 USP2 (0.43) ALDH1A1SSTR5PKMMAPK1GLA
SCHEMBL3130702 0.81 USP2 (0.42) ALDH1A1SSTR5PKMMAPK1GLA
SCHEMBL3128667 0.81 SSTR5 (0.48) ALDH1A1SSTR5PKMMAPK1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2142528-B1 1-(1-BENZYLPIPERIDIN-4-YL)BENZIMIDAZ0LE -5-CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF DIABETES MELLITUS HOFFMANN LA ROCHE (CH) 2010-07-07 EP claimed